Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

Overview of attention for article published in Journal of Hematology & Oncology, April 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy: 1 policy source

twitter: 3 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

selinexor

Cited by Canadian Agency for Drugs and Technologies in Health on 12 Oct 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.